Cardiospecific Sevoflurane Treatment Quenches Inflammation but does not Attenuate Myocardial Cell Damage Markers: A Proof-of-Concept Study in Patients Undergoing Mitral Valve Repair
This proof-of-concept study suggests that intramyocardial delivery compared with the systemic delivery of sevoflurane more strongly attenuates the systemic inflammatory response
